Genetron Holdings Ltd's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2022 to a ratio of 2.68, above the company average. This is a clear sign of healthy business climate in the Medical Laboratories industry and improving liquidity at their respective customers, during the fourth quarter 2022. Average receivable collection period, for the Genetron Holdings Ltd in Dec 31 2022 quarter, has decreased to 136 days, compared to 164 days, in the 0 quarter.

If we take a look into Healthcare sector 183 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2022 from 0 to 1907.

What is Receivable Turnover Ratio?
What is Genetron Holdings Ltd Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GTH Receivables Turnover Ratio	(Dec 31 2022) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2021) IV. Quarter
Y / Y Receivable Change	-20.37 %	-20.37 %	-20.37 %	-20.37 %	75.5 %
Y / Y Revenue Change	13.02 %	-	-	-	28.31 %
Receivable Turnover Ratio (TTM)	2.68	2.23	2.1	1.99	1.89
GTH's Total Ranking	# 1907	# 0	# 4050	# 0	# 3690
Accounts Receivable average collection period days	136	164	174	184	194
Seq. Receivable Change	0 %	0 %	0 %	-20.37 %	0 %
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Medical Laboratories Industry	# 9
Healthcare Sector	# 184
Overall Market	# 1907

Receivable Turnover Ratio Statistics
High	Average	Low
0.67	0.41	0.22
(Dec 31 2022)		(Dec 31 2020)

GTH Company Profile • Back to GTH Efficiency Comparisons • Compare GTH Receivables Turnover Ratio to its Competitors

Financial Statements
Genetron Holdings Ltd's Accounts Receivable	$ 35 Millions	Visit GTH's Balance sheet
Genetron Holdings Ltd's Sales TTM	$ 94 Millions	Visit GTH's Income Statement
Sources of GTH's Revenues		Visit GTH's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
GTH's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
GTH's Growth Rates	GTH's Roa	GTH's Inventory Turnover Ratio	GTH's Dividend Comparisons
GTH's Profitability Ratios	GTH's Roi	GTH's Asset Turnover Ratio	GTH's Dividend Growth
GTH's Valuation Ratios	GTH's Roe	GTH's Financial Strength Ratios	GTH's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2022	Receivable at quarter ending Dec 31 2022
Evolus Inc	7.32	$ 148.616 Millions	$ 20.299 Millions
Encompass Health Corporation	7.31	$ 4,348.600 Millions	$ 594.775 Millions
Inventiva S a	7.30	$ 13.640 Millions	$ 1.868 Millions
Pfizer Inc	7.24	$ 100,330.000 Millions	$ 13,852.000 Millions
3m Company	7.21	$ 34,229.000 Millions	$ 4,745.750 Millions
Alphatec Holdings Inc	7.19	$ 350.867 Millions	$ 48.787 Millions
Quidelortho Corp	7.18	$ 3,266.000 Millions	$ 454.879 Millions
Alpha Teknova Inc	7.18	$ 41.420 Millions	$ 5.769 Millions
Illumina Inc	7.18	$ 4,584.000 Millions	$ 638.750 Millions
Etao International Co Ltd	7.17	$ 58.060 Millions	$ 8.096 Millions
Nuwellis Inc	7.16	$ 8.543 Millions	$ 1.193 Millions
Star Equity Holdings Inc	7.16	$ 112.151 Millions	$ 15.657 Millions
Eiger Biopharmaceuticals Inc	7.16	$ 13.484 Millions	$ 1.883 Millions
Delcath Systems Inc	7.16	$ 2.719 Millions	$ 0.380 Millions
Maravai Lifesciences Holdings Inc	7.16	$ 883.001 Millions	$ 123.351 Millions
Universal Health Services Inc	7.14	$ 13,399.370 Millions	$ 1,877.577 Millions
Minerva Surgical Inc	7.13	$ 50.294 Millions	$ 7.050 Millions
Pacira Biosciences inc	7.11	$ 666.823 Millions	$ 93.769 Millions
Ambrx Biopharma Inc	7.11	$ 11.911 Millions	$ 1.675 Millions
Enzo Biochem Inc	7.11	$ 81.120 Millions	$ 11.415 Millions
Veracyte Inc	7.10	$ 296.536 Millions	$ 41.755 Millions
Pulmonx Corporation	7.10	$ 53.662 Millions	$ 7.557 Millions
Brainsway Ltd	7.08	$ 27.177 Millions	$ 3.837 Millions
Icon Plc	7.07	$ 7,741.386 Millions	$ 1,094.838 Millions
Lakeland Industries Inc	7.07	$ 112.846 Millions	$ 15.964 Millions
Puma Biotechnology Inc	7.05	$ 228.031 Millions	$ 32.352 Millions
Clearpoint Neuro Inc	7.05	$ 20.551 Millions	$ 2.917 Millions
Intuitive Surgical Inc	7.04	$ 6,222.200 Millions	$ 884.075 Millions
Finch Therapeutics Group Inc	7.03	$ 0.861 Millions	$ 0.122 Millions
Aspira Women s Health inc	6.97	$ 8.184 Millions	$ 1.174 Millions

Date modified: 2026-06-22T16:58:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.